These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 9160528)

  • 1. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Vaccine; 1997 Apr; 15(5):575-82. PubMed ID: 9160528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of wild-type and severe combined immunodeficiency mice against an intranasal challenge by passive immunization with monoclonal antibodies to the Chlamydia trachomatis mouse pneumonitis major outer membrane protein.
    Pal S; Bravo J; Peterson EM; de la Maza LM
    Infect Immun; 2008 Dec; 76(12):5581-7. PubMed ID: 18809664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection.
    Cotter TW; Meng Q; Shen ZL; Zhang YX; Su H; Caldwell HD
    Infect Immun; 1995 Dec; 63(12):4704-14. PubMed ID: 7591126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection.
    Peterson EM; Cheng X; Motin VL; de la Maza LM
    Infect Immun; 1997 Jul; 65(7):2693-9. PubMed ID: 9199438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
    Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
    Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
    Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
    Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
    Pal S; Peterson EM; Rappuoli R; Ratti G; de la Maza LM
    Vaccine; 2006 Feb; 24(6):766-75. PubMed ID: 16199110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge.
    Pal S; Theodor I; Peterson EM; de la Maza LM
    Infect Immun; 2001 Oct; 69(10):6240-7. PubMed ID: 11553566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
    Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
    Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
    Pal S; Davis HL; Peterson EM; de la Maza LM
    Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies.
    Brossay L; Villeneuve A; Paradis G; Coté L; Mourad W; Hébert J
    Infect Immun; 1994 Feb; 62(2):341-7. PubMed ID: 7507888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of neutralization of Chlamydia trachomatis infection by high avidity monoclonal antibodies to surface-exposed major outer membrane protein variable domain IV.
    Degn LLT; Bech D; Christiansen G; Birkelund S
    Mol Immunol; 2023 Nov; 163():163-173. PubMed ID: 37801817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partial protection against genital reinfection by immunization of guinea-pigs with isolated outer-membrane proteins of the chlamydial agent of guinea-pig inclusion conjunctivitis.
    Batteiger BE; Rank RG; Bavoil PM; Soderberg LS
    J Gen Microbiol; 1993 Dec; 139(12):2965-72. PubMed ID: 7510322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codon usage bias in Chlamydia trachomatis and the effect of codon modification in the MOMP gene on immune responses to vaccination.
    Zheng Y; Zhao WM; Wang H; Zhou YB; Luan Y; Qi M; Cheng YZ; Tang W; Liu J; Yu H; Yu XP; Fan YJ; Yang X
    Biochem Cell Biol; 2007 Apr; 85(2):218-26. PubMed ID: 17534403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Chlamydia trachomatis-specific Th2 clone does not provide protection against a genital infection and displays reduced trafficking to the infected genital mucosa.
    Hawkins RA; Rank RG; Kelly KA
    Infect Immun; 2002 Sep; 70(9):5132-9. PubMed ID: 12183563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars.
    Qu Z; Cheng X; de la Maza LM; Peterson EM
    Infect Immun; 1993 Apr; 61(4):1365-70. PubMed ID: 7681045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis.
    Zhang YX; Stewart S; Joseph T; Taylor HR; Caldwell HD
    J Immunol; 1987 Jan; 138(2):575-81. PubMed ID: 3540122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses.
    Dong-Ji Z; Yang X; Shen C; Lu H; Murdin A; Brunham RC
    Infect Immun; 2000 Jun; 68(6):3074-8. PubMed ID: 10816446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
    Igietseme JU; Murdin A
    Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.